These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

469 related items for PubMed ID: 16596267

  • 21. Lack of correlation between the antibody to hepatitis B core antigen and survival after surgical resection for hepatitis C virus-related hepatocellular carcinoma.
    Nishikawa H, Arimoto A, Wakasa T, Kita R, Kimura T, Osaki Y.
    Oncol Rep; 2013 Jul; 30(1):91-8. PubMed ID: 23615658
    [Abstract] [Full Text] [Related]

  • 22. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
    Chiaramonte M, Stroffolini T, Vian A, Stazi MA, Floreani A, Lorenzoni U, Lobello S, Farinati F, Naccarato R.
    Cancer; 1999 May 15; 85(10):2132-7. PubMed ID: 10326690
    [Abstract] [Full Text] [Related]

  • 23. Mutual confounding and interactive effects between hepatitis C and hepatitis B viral infections in hepatocellular carcinogenesis: a population-based case-control study in Taiwan.
    Sun CA, Farzadegan H, You SL, Lu SN, Wu MH, Wolfe L, Hardy W, Huang GT, Yang PM, Lee H, Chen CJ.
    Cancer Epidemiol Biomarkers Prev; 1996 Mar 15; 5(3):173-8. PubMed ID: 8833617
    [Abstract] [Full Text] [Related]

  • 24. Prevalence of hepatocellular carcinoma in patients with alcoholic cirrhosis and prior exposure to hepatitis C.
    Yamauchi M, Nakahara M, Maezawa Y, Satoh S, Nishikawa F, Ohata M, Mizuhara Y, Hirakawa J, Nakajima H, Fujisawa K.
    Am J Gastroenterol; 1993 Jan 15; 88(1):39-43. PubMed ID: 7678368
    [Abstract] [Full Text] [Related]

  • 25. [Serum anti-hepatitis C virus and hepatitis C virus RNA in patients with hepatocellular carcinoma].
    Jiang MD.
    Zhonghua Yi Xue Za Zhi; 1993 Mar 15; 73(3):131-4, 189. PubMed ID: 7686810
    [Abstract] [Full Text] [Related]

  • 26. [Low prevalence of ant-hepatitis c virus antibodies in hepatocellular carcinoma in Senegal].
    Ka MM, Herve P, Leguenno B, Ndiaye MF, Diop TM, Diop B, Dangou JM, Bao O, Brechot C.
    Ann Gastroenterol Hepatol (Paris); 1996 Mar 15; 31(6):329-32. PubMed ID: 8920074
    [Abstract] [Full Text] [Related]

  • 27. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR, Mathur A, Mathur D, Udawat HP, Nepalia S, Nijhawan S, Mathur A.
    Trop Gastroenterol; 2007 Mar 15; 28(1):19-23. PubMed ID: 17896605
    [Abstract] [Full Text] [Related]

  • 28. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
    Fattovich G, Pantalena M, Zagni I, Realdi G, Schalm SW, Christensen E, European Concerted Action on Viral Hepatitis (EUROHEP).
    Am J Gastroenterol; 2002 Nov 15; 97(11):2886-95. PubMed ID: 12425564
    [Abstract] [Full Text] [Related]

  • 29. Epidemiology of hepatocellular carcinoma. Evaluation of viral and other risk factors in a low-endemic area for hepatitis B and C.
    Peters M, Wellek S, Dienes HP, Junginger T, Meyer J, Meyer Zum Büschendfelde KH, Gerken G.
    Z Gastroenterol; 1994 Mar 15; 32(3):146-51. PubMed ID: 8197809
    [Abstract] [Full Text] [Related]

  • 30. Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area.
    Huang YH, Wu JC, Chen CH, Chang TT, Lee PC, Chau GY, Lui WY, Chang FY, Lee SD.
    Liver Int; 2005 Apr 15; 25(2):236-41. PubMed ID: 15780044
    [Abstract] [Full Text] [Related]

  • 31. Anti-hepatitis B core positivity as a risk factor for hepatocellular carcinoma in alcoholic cirrhosis: a case-control study.
    Kwon OS, Jung YK, Bae KS, Kim JH, Kim SG, Kim YS, Lee JI, Lee JW, Kim YS.
    Alcohol; 2012 Sep 15; 46(6):537-41. PubMed ID: 22572059
    [Abstract] [Full Text] [Related]

  • 32. Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population.
    Tanaka K, Hirohata T, Koga S, Sugimachi K, Kanematsu T, Ohryohji F, Nawata H, Ishibashi H, Maeda Y, Kiyokawa H.
    Cancer Res; 1991 Jun 01; 51(11):2842-7. PubMed ID: 1851661
    [Abstract] [Full Text] [Related]

  • 33. Ursodiol use is possibly associated with lower incidence of hepatocellular carcinoma in hepatitis C virus-associated liver cirrhosis.
    Tarao K, Fujiyama S, Ohkawa S, Miyakawa K, Tamai S, Hirokawa S, Masaki T, Tanaka K.
    Cancer Epidemiol Biomarkers Prev; 2005 Jan 01; 14(1):164-9. PubMed ID: 15668491
    [Abstract] [Full Text] [Related]

  • 34. [Investigation of hemodialysis patients in terms of the presence of occult hepatitis B].
    Altindiş M, Uslan I, Cetinkaya Z, Yüksel S, Ciftçi IH, Demirtürk N, Ozdemir M, Arslan F, Aktepe OC.
    Mikrobiyol Bul; 2007 Apr 01; 41(2):227-33. PubMed ID: 17682709
    [Abstract] [Full Text] [Related]

  • 35. Response to hepatitis B vaccine in HIV-1-positive subjects who test positive for isolated antibody to hepatitis B core antigen: implications for hepatitis B vaccine strategies.
    Gandhi RT, Wurcel A, Lee H, McGovern B, Shopis J, Geary M, Sivamurthy R, Sax PE, Ukomadu C.
    J Infect Dis; 2005 May 01; 191(9):1435-41. PubMed ID: 15809901
    [Abstract] [Full Text] [Related]

  • 36. High prevalence of transfusion-transmitted virus among patients with non-B, non-C hepatocellular carcinoma.
    Nakagawa N, Ikoma J, Ishihara T, Yasui N, Fujita N, Iwasa M, Kaito M, Watanabe S, Adachi Y.
    Cancer; 1999 Oct 15; 86(8):1437-40. PubMed ID: 10526270
    [Abstract] [Full Text] [Related]

  • 37. Relation between antibody to hepatitis B core antigen and survival after curative therapy for non-B non-C hepatocellular carcinoma.
    Nishikawa H, Osaki Y, Arimoto A, Kita R, Kimura T.
    Anticancer Res; 2013 May 15; 33(5):2211-9. PubMed ID: 23645778
    [Abstract] [Full Text] [Related]

  • 38. HBV and HCV infection in Japanese dental care workers.
    Nagao Y, Matsuoka H, Kawaguchi T, Ide T, Sata M.
    Int J Mol Med; 2008 Jun 15; 21(6):791-9. PubMed ID: 18506374
    [Abstract] [Full Text] [Related]

  • 39. Hepatitis G virus infection in patients with hepatocellular carcinoma in Recife, Brazil.
    Leão-Filho GC, Lopes EP, Ferraz AA, Moura I, Pernambuco JR, Reis C, Silva AE, Ferraz ML.
    Jpn J Clin Oncol; 2007 Aug 15; 37(8):632-6. PubMed ID: 17704535
    [Abstract] [Full Text] [Related]

  • 40. Hepatitis C virus infection as a major risk factor for hepatocellular carcinoma.
    Caselmann WH, Alt M.
    J Hepatol; 1996 Aug 15; 24(2 Suppl):61-6. PubMed ID: 8836891
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.